Women's Health Issues
Volume 17, Issue 4 , Pages 256-263 , July 2007

Methamphetamine Use by Incarcerated Women: Comorbid Mood and Anxiety Problems

  • Peter W. Vik, PhD

      Affiliations

    • Corresponding Author InformationCorrespondence to: Peter Vik, PhD, Department of Psychology, Idaho State University, Pocatello, ID 83209-8112; Phone: 208-282-3541; fax: 282-4832.

Received 28 March 2006 ,Revised 8 September 2006 ,Accepted 22 December 2006.

References 

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. (4th ed.). 1994;Washington, DC: Author.
  2. Anglin MD, Burke C, Perrochet B, Stamper W, Dawud-Noursi S. History of the methamphetamine problem. Journal of Psychoactive Drugs. 2000;32:137–141
  3. Babor TF, Del Boca FK. Just the facts: Enhancing measurement of alcohol consumption using self-report methods. In:  Litten RZ,  Allen JP editor. Measuring alcohol consumption: Psychosocial and biochemical methods. Totowa, NJ: Humana Press; 1992;p. 3–19
  4. Brady KT, Sonne SC. The role of stress in alcohol use, alcoholism treatment, and relapse. Alcohol Research & Health. 1999;23(4):263–271
  5. Brown SA, Myers MG, Lippke L, Tapert SF, Stewart DG, Vik PW. Psychometric evaluation of the Customary Drinking and Drug Use Record (CDDR): A measure of adolescent alcohol and drug involvement. Journal of Studies on Alcohol. 1998;59:427–438
  6. Connors GJ, Donovan DM, DiClemente CC. Substance abuse treatment and the stages of change: Selecting and planning interventions. New York: The Guilford Press; 2002;
  7. Daniel AE, Robins AJ, Wilfley DE. Lifetime and six-month prevalence of psychiatric disorders among sentenced female offenders. Bulletin of the American Academy of Psychiatry and the Law. 1988;16:333–342
  8. Del Boca FK, Noll JA. Truth or consequences: The validity of self-report data in health services research on addictions. Addiction. 2000;95(Suppl. 3):S347–S360
  9. Derogatis LR. Brief Symptom Inventory: Administration, scoring, and procedures manual. (3rd ed.). Minneapolis: National Computer Systems, Inc; 1993;
  10. Endicott J, Spitzer RL. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry. 1978;35:837–844
  11. Grice DE, Brady KT, Dustan LR, Malcolm R, Kilpatrick DG. Sexual and physical assault history and posttraumatic stress disorder in substance-dependent individuals. The American Journal on Addictions. 1995;4:297–305
  12. Jordan BK, Schlenger WE, Fairbank JA, Caddell JM. Prevalence of psychiatric disorders among incarcerated women: Convicted felons entering prison. Archives of General Psychiatry. 1996;53:513–519
  13. Kalechstein AD, Newton TF, Longshore D, Anglin MD, van Gorp WG, Gawin FH. Psychiatric comorbidity of methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neuroscience. 2000;12:480–484
  14. Kessler RC, Crum RM, Warner LA, Nelson CB. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry. 1997;54:313–321
  15. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51:8–19
  16. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of General Psychiatry. 2004;61:73–84
  17. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Auilar-Gaziola S, et al. Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology. Addictive Behaviors. 1998;23:893–908
  18. Murray JB. Psychophysiological aspects of amphetamine-methamphetamine abuse. Journal of Psychology. 1998;132:227–237
  19. Myrick H, Cluver H, Swavely S. Diagnosis and treatment of co-occurring affective disorders and substance use disorders. Psychiatric Clinics of North America. 2004;27:649–659
  20. Nelson-Zlupko L, Kauffman E, Dore MM. Gender differences in drug addiction and treatment: Implications for social work intervention with substance-abusing women. Social Work. 1995;40:45–53
  21. Powis B, Griffiths P, Gossop M, Strang J. The differences between male and female drug users: Community samples of heroin and cocaine users compared. Substance Use and Misuse. 1996;31:529–543
  22. Ramlow BE, White AL, Watson DD, Leukefeld CG. The needs of women with substance use problems: An expanded vision for treatment. Substance Use and Misuse. 1997;32:1395–1404
  23. Reiger DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Co-morbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association. 1990;264:2511–2518
  24. Riehman KS, Iguchi MY, Anglin MD. Depressive symptoms among amphetamine and cocaine users before and after substance abuse treatment. Psychology of Addictive Behaviors. 2002;16:333–337
  25. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics, and validity. Archives of General Psychiatry. 1981;38:381–389
  26. Rosenthal RN, Westreich L. Treatment of persons with dual diagnoses of substance use disorders and other psychological problems. In:  McCrady BS,  Epstein EE editor. Addictions: A comprehensive guidebook. New York: Oxford University Press; 1999;p. 439–476
  27. Schuckit MA. Alcohol and depression: A clinical perspective. Acta Psychiatrica Scandinavica. 1994;89(Suppl. 377):28–32
  28. Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. American Journal of Psychiatry. 2001;158:1206–1214
  29. Teplin LA, Abram KM, McClelland GM. Prevalence of psychiatric disorders among incarcerated women: Pretrial jail detainees. Archives of General Psychiatry. 1996;53:505–512
  30. Vik PW, Ross T. Methamphetamine use among incarcerated women. Journal of Substance Use. 2003;8:69–77
  31. Wallen J. A comparison of male and female clients in substance abuse treatment. Journal of Substance Abuse Treatment. 1992;9:243–248
  32. Weiss RD, Najavits LM, Mirin SM. Substance abuse and psychiatric disorders. In:  Frances RJ,  Miller SI editor. Clinical textbook of addictive disorders. 2nd ed.. New York: The Guilford Press; 1998;p. 291–318
  33. Zweben JE. Psychiatric problems among alcohol and other drug dependent women. Journal of Psychoactive Drugs. 1996;28:345–366
  34. Zweben JE, Cohen J, Christian D, Galloway GP, Salinardi M, Parent D, et al. Psychiatric symptoms in methamphetamine users. American Journal on Addictions. 2004;13:181–190

PII: S1049-3867(07)00004-7

doi: 10.1016/j.whi.2006.12.004

Women's Health Issues
Volume 17, Issue 4 , Pages 256-263 , July 2007

Article Tools